GLP1R and obesity disorder: GLP-1R agonists like as liraglutide are currently widely used in the clinic as second-line therapy for type II diabetes, and GLP-1R agonists have been used in the clinical treatment of obesity in countries such as Korea and the United States (3, 4, 5).